Chinese authorities are now piloting a monitoring system for respiratory diseases.
China is currently grappling with an outbreak of the Human Metapneumovirus (HMPV), which is spreading rapidly across the country. This comes five years after the Covid-19 pandemic, as reports and social media posts suggest that the virus is causing a surge in flu-like and Covid-19-like symptoms. There are increasing concerns that hospitals and crematories are becoming overwhelmed, with some videos circulating online showing crowded emergency rooms and patients seeking care in high numbers.
In addition to HMPV, multiple other viruses, including Influenza A, Mycoplasma pneumoniae, and Covid-19, are reportedly circulating in China, further straining the healthcare system. A social media post from the account 'SARS-CoV-2 (Covid-19)' highlighted the rising strain on children's hospitals, noting an alarming increase in pneumonia cases and "white lung" conditions among younger patients.
While rumors have emerged claiming that China has declared a state of emergency due to the outbreak, these reports remain unconfirmed. Health officials are continuing to closely monitor the situation as HMPV spreads, given its resemblance to the symptoms of both the flu and Covid-19.
In response to the growing number of respiratory illnesses, China’s disease control authority announced plans to pilot a new monitoring system to track pneumonia cases of unknown origin.
According to a report by Reuters, the system will help authorities identify and manage unknown pathogens, with the goal of improving preparedness for potential new health threats. This initiative will allow laboratories to report cases more efficiently and ensure the timely verification and handling of outbreaks by disease control agencies.
Recent data reveals an uptick in acute respiratory infections in China during the week of December 16 to 22, with officials anticipating further rises in cases through the winter months. Kan Biao, a spokesperson from the National Disease Control and Prevention Administration, warned that a range of respiratory diseases is expected to affect the population during the winter and spring. However, he reassured the public that the overall number of cases this year would likely be lower than in the previous year.
Among the detected pathogens, HMPV is showing a particularly noticeable rise in infections, particularly among children under 14, especially in northern regions. Experts are urging caution regarding the use of antiviral drugs for treating HMPV, as there is currently no vaccine for the virus, and its symptoms are similar to those of the common cold.
As China braces for a challenging winter season, health authorities are focused on improving surveillance and ensuring preparedness to combat both known and emerging respiratory threats.
